Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT02205268
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with ADHD aged 7 to 17 years
* Patient and legal guardian able to communicate in English
* Patient has been living with parent/guardian for at least six months
* Patient attending school for at least 2 days / week
* ADHD as primary disorder with symptoms present for at least 9 months
* Participants on medication treatment for ADHD must have been on a stable dose for 3 months prior to commencement of the treatment
Exclusion Criteria:
* Significant visual or hearing impairment that would preclude use of NIRS- neurofeedback
* Global learning disability, Autism, psychosis, bipolar disorder, depression, suicidal ideation, or another psychiatric disorder requiring treatment with additional psychotropic medication, current substance dependance or regular use, and severe sleep disorders
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
17 Years
Study:
NCT02205268
Study Brief:
Protocol Section:
NCT02205268